Skip to main content
. 2013 Dec 5;14:270. doi: 10.1186/1471-2369-14-270

Table 1.

/Baseline demographics in patients undergoing elective coronary procedures

Characteristic No CI-AKI CI-AKI CI-AKI (S1) CI-AKI (S2) P value
Number of subject
114
16
13
3
 
CKD stage III: CKD stage IV
90:24
10:6
9:4
1:2
 
Age (yr)
70 ± 10
72 ± 7
73 ± 5
70 ± 9
0.67
Men: women
88:26
12:4
10:3
2:1
0.17
SBP (mmHg)
129 ± 17
125 ± 13
125 ± 14
124 ± 14
0.65
DBP(mmHg)
71 ± 10
69 ± 12
70 ± 12
67 ± 8
0.74
Heart rate
75 ± 10
74 ± 12
76 ± 11
72 ± 8
0.48
Height (cm)
162 ± 9
161 ± 9
160 ± 7
162 ± 8
0.85
Weight (kg)
60 ± 13
56 ± 7
58 ± 5
54 ± 8
0.16
Body mass index (kg/m2)
24 ± 4
23 ± 3
23 ± 3
21 ± 4
0.14
Diabetes mellitus (%)
42
44
46
33
0.25
Hypertension (%)
80
75
77
67
0.19
Hypercholesterolemia (%)
50
44
38
67
0.16
Myocardial infarction (%)
18
25
23
33
0.37
LVEF < 40% (%)
20
19
15
33
0.59
CCS > II (%)
96
94
92
100
0.49
NYHA > II (%)
44
44
38
67
0.6
Angiogram/PCI (%)
66
75
85
67
0.58
Number of vessel disease > 1 (%)
61
63
50
67
0.62
ACEI (%)
30
31
31
33
0.42
ATRA (%)
40
31
31
33
0.48
Beta blocker (%)
54
44
38
67
0.56
CCB (%)
28
31
31
33
0.26
Diuretic (%)
26
31
31
33
0.64
Aspirin (%)
72
63
62
67
0.51
Statin (%)
48
44
38
67
0.17
Nitrate (%)
38
38
31
67
0.14
Contrast volume (ml)
126 ± 65
129 ± 90
126 ± 80
124 ± 92
0.43
IV volume (ml)
1483 ± 453
1591 ± 260
1598 ± 246
1562 ± 128
0.48
Total risk score 8 ± 3 8 ± 3 8 ± 3 9 ± 1 0.24

CI-AKI indicates contrast induced acute kidney injury, CI-AKI (S1) indicates CI-AKI stage I, CI-AKI (S2) indicates CI-AKI stage II, SBP indicates systolic blood pressure, DBP indicates diastolic blood pressure, LVEF indicates left ventricular ejection fraction, CCS indicates Canadian Cardiovascular Society, NYHA indicates New York Heart Association, PCI indicates percutaneous intervention, CCB indicates calcium channel blocker.